Search Results for "Mail.somaiya.com"

16:01 EST 27th January 2015 | BioPortfolio

Matching Channels

None

Matching News

Alexion Pharmaceuticals-Aktie: Überlegene Nachhaltigkeit in Biotechbranche, Abstufung wegen Bewertung! - Aktienanalyse

London - Alexion Pharmaceuticals -Aktienanalyse von Analyst M. Ian Somaiya von Nomura Equity Research: Im Rahmen einer aktuellen Aktienanalyse äußert Analyst M. Ian Somaiya vom Investmenthaus Nomur....

Amgen-Aktie: Branchenstudie Biotechsektor, mehr Vertaruen in evolocumab! - Aktienanalyse

London - Amgen-Aktienanalyse des Analysten M. Ian Somaiya von Nomura Equity Research: M. Ian Somaiya, Aktienanalyst von Nomura Equity Research, spricht laut einer Aktienanalyse nach wie vor eine Ka...

Gilead Sciences-Aktie: Hepatitis C-Schätzungen angehoben, Sorge um AbbVie-Preise! - Aktienanalyse

London - Gilead Sciences-Aktienanalyse von Analyst M. Ian Somaiya von Nomura Equity Research: Der Aktienanalyst M. Ian Somaiya vom Investmenthaus Nomura Equity Research empfiehlt die Aktien des US-...

Gilead Sciences-Aktie: AbbVie heizt den Konkurrenzkampf mit aggressiveren Preisen an! - Aktienanalyse

London - Gilead Sciences-Aktienanalyse von Analyst M. Ian Somaiya von Nomura Equity Research: Der Aktienanalyst M. Ian Somaiya vom Investmenthaus Nomura Equity Research empfiehlt die Aktien des US-...

Gilead Sciences-Aktie: Zugang zu Hepatitis C-Medikamemt wird leichter! - Aktienanalyse

London - Gilead Sciences-Aktienanalyse von Analyst M. Ian Somaiya von Nomura Equity Research: Der Aktienanalyst M. Ian Somaiya vom Investmenthaus Nomura Equity Research empfiehlt die Aktien des US-...

Celgene-Aktie: positive Abraxane-Ergebnisse, Top-Empfehlung für 2015! - Aktienanalyse

London - Celgene-Aktienanalyse von Analyst M. Ian Somaiya von Nomura Equity Research: Aktienanalyst M. Ian Somaiya vom Investmenthaus Nomura Equity Research hat seine Kaufempfehlung für die Aktie d.....

Biogen Idec-Aktie: Tysabri-Umsätze könnten wegen Sanofi's Lemtrada leiden, Abstufung! - Aktienanalyse

London - Biogen Idec-Aktienanalyse von Analyst M. Ian Somaiya von Nomura Equity Research Der Aktienanalyst M. Ian Somaiya von Nomura Equity Research äußert laut einer Aktienanalyse zu den Aktien de....

Anonymous E-Mail Alleges GSK Bribery In Syria

In an apparent replay of the beginning of GlaxoSmithKline's compliance scandal in China, an anonymous e-mail has been sent to the UK-based multinational's top executives calling their attention to the...

Matching PubMed Articles

You've Got Mail … and Need Follow-up: The Effect and Patient Perception of E-mail Follow-up Reminders After Emergency Department Discharge.

The hypothesis was that a reminder about recommended primary care physician (PCP) follow-up, sent via e-mail to patients discharged from the emergency department (ED), would increase the proportion of...

Successful Practices in the Use of Secure E-mail.

Physician use of secure e-mail with patients is anticipated to increase under Stage 2 Meaningful Use requirements, but little is known about how physicians can successfully incorporate it into daily w...

E-mail communication in the management of gastroenterology patients: A review.

E-mail correspondence between physicians and patients can be a useful tool to improve communication efficiency, provide economic and ecological benefits, improve therapeutic interventions and adherenc...

Potential Limitations of E-mail and Text Messaging in Improving Adherence in Glaucoma and Ocular Hypertension.

To determine how receptive patients are to the use of e-mail and text message reminders for appointments and medications.

"While You Still Think, I Already Type": Experienced Social Power Reduces Deliberation During E-Mail Communication.

Abstract E-mail allows individuals to deliberate on their communication before sending it off. For instance, communication partners can easily take their time to ponder how best to frame a request bef...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement